Related Experiment Video
Updated: May 15, 2026

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
The immune response: targets for the treatment of severe sepsis
Aline M Bernard1, Gordon R Bernard
1Division of Critical Care, Department of Pediatrics, University of Colorado School of Medicine, 13121 E 17th Avenue, MS 8414, Aurora, CO 80045-2535, USA ; Division of Pediatric Critical Care, Children's Hospital Colorado, 13123 East 16th Avenue, Aurora, CO 80045, USA.
Abstract:
The clinical process of severe sepsis is characterized by extreme inflammation interlinked with potent stimulation of the coagulation cascade often followed by a state of relative immune paralysis. In this paper, we will review many of the potential therapies directed at various steps along the inflammatory cascade from modulation of inflammatory mediators eliciting the immune response, alteration of the host's immune response in both a stimulatory and depressive manner, and taming the overexuberant coagulation response triggered by the fierce coagulation-inflammation cycle. Finally, we will discuss further opportunities for research to improve our ability to design effective therapies.
Insights
Severe sepsis involves extreme inflammation and coagulation, leading to immune paralysis. This review explores therapies targeting inflammation, immune response modulation, and coagulation to improve sepsis treatment.
Area of Science:
- Critical care medicine
- Immunology
- Hematology
Background:
- Severe sepsis presents a complex interplay of systemic inflammation and coagulation activation.
- This often results in a paradoxical state of immune suppression, hindering effective host defense.
- The coagulation-inflammation cycle is a critical factor in sepsis pathophysiology.
Purpose of the Study:
- To review current and potential therapies for severe sepsis.
- To explore strategies for modulating the inflammatory and immune responses.
- To examine approaches for managing the coagulation cascade in sepsis.
Main Methods:
- Literature review of clinical and preclinical studies on sepsis therapies.
- Analysis of therapeutic targets within the inflammatory and coagulation pathways.
- Discussion of immunomodulatory strategies, both stimulatory and suppressive.
Main Results:
- Multiple therapeutic targets exist along the inflammatory cascade.
- Modulating the host immune response offers potential treatment avenues.
- Controlling the hypercoagulable state is crucial for managing sepsis.
Conclusions:
- Targeting inflammation, immune response, and coagulation offers multifaceted therapeutic opportunities.
- Further research is needed to optimize sepsis treatment strategies.
- Developing effective therapies requires a comprehensive understanding of the coagulation-inflammation cycle.
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Acute Pyelonephritis II: Diagnostic Studies and Management
Humoral Immune Responses
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

